Mereo BioPharma Group plc financial statements
Mereo BioPharma Group plc's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 500K | 10-K |
| Net income | −USD 41.88M | 10-K |
| Cash and equivalents | USD 40.99M | 10-Q |
| Total debt | USD 202K | EODHD |
Mereo BioPharma Group plc financials on 6ix · Mereo BioPharma Group plc on 6ix